Categories Analysis, Earnings, Health Care

Earnings preview: Cardiovascular to drive Boston Scientific Q4 results

Boston Scientific Corporation (BSX) is set to report its fourth-quarter earnings results on Wednesday before the bell. The medical device manufacturer’s results will be driven by stable demand across all operating segments and geographical regions.

Investors remain positive about the major contribution from the Cardiovascular business group, which comprises Interventional Cardiology (IC) and Peripheral Interventions (PI). The company has exceeded analysts’ expectations for three consecutive quarters.

Analysts expect Boston Scientific to post earnings of $0.37 per share on revenue of $2.56 billion for the fourth quarter. In comparison, during the previous year quarter, the company reported a profit of $0.34 per share on revenue of $2.41 billion. Majority of the analysts recommended a “strong buy” or “buy” rating while expecting the stock to reach $42.22 per share in the next 52 weeks.

The robust commercial teams and innovative portfolio could remain as the backbone of IC business for maintaining its global growth. The IC business growth would be benefited by the complex percutaneous coronary intervention (PCI) products despite a decline in the coronary drug-eluting stent business. The company’s Structural Heart results will be aided by Watchman, Acurate and Iris product lines as well as the recently acquired Clarent Medical.

The growth in the peripheral arterial disease, venous and interventional oncology drugs could drive the PI business higher. After the launch of Eluvia drug-eluting stent in the US, the quarterly results could be benefited by the large patient audience, differentiated, sustained-release technology and superior clinical outcomes with minimal need for reintervention.

Also read: Google, Disney, EA, GM and Twitter on earnings lineup

In the third quarter, Boston Scientific posted a 53% jump in earnings driven by higher other income as well as an increase in the top line. Net sales increased by 7.7% on higher sales growth across all segments. Sales at MedSurg division grew 10.3% while the Rhythm and Neuro segment registered a 7.4% gain. Cardiovascular sales were higher by 5.9% compared to last year.

Looking ahead into the full year 2018, the company had expected revenues in the range of $9.787 billion to $9.827 billion and earnings in the range of $1.08 to $1.10 per share. Adjusted earnings were anticipated to be in the range of $1.37 to $1.41 per share.

For the fourth quarter, the company had predicted sales in the range of $2.525 billion to $2.565 billion and earnings in the range of $0.15 to $0.17 per share. Adjusted earnings were projected to be in the range of $0.30 to $0.32 per share.

Investors were concerned about the ongoing trade tariff tensions between the US and China as the top line numbers could be hurt by a single adverse move for the coming quarters. The company is already gaining presence in the emerging markets of Brazil, Russia, India, and China (BRIC) and currently targeting about 10 emerging markets for additional emphasis.

Shares of Boston Scientific opened lower but changed course to the green territory on Monday afternoon. The stock has risen over 38% in the past year and over 3% in the past three months.

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Comments

  1. Pingback: Leandro Farland
  2. Pingback: Chirurgie Tunisie
  3. Pingback: future university
  4. Pingback: Campus facilities
  5. Pingback: Political Science
  6. Pingback: Dental Implants
  7. Pingback: Technical Writer
  8. Pingback: Pharmacognos
  9. Pingback: Career development
  10. Pingback: العقاقير
  11. Pingback: FUE
  12. Pingback: led lineari
  13. Pingback: Luce lineare LED
  14. Pingback: Fiverr Earn
  15. Pingback: Fiverr Earn
  16. Pingback: Fiverr Earn
  17. Pingback: Fiverr Earn
  18. Pingback: Fiverr Earn
  19. Pingback: fiverrearn.com
  20. Pingback: fiverrearn.com
  21. Pingback: fiverrearn.com
  22. Pingback: fiverrearn.com
  23. Pingback: fiverrearn.com
  24. Pingback: endopump buy
  25. Pingback: TMS System
  26. Pingback: 3pl Broker
  27. Pingback: clima
  28. Pingback: fiverrearn.com
  29. Pingback: french bulldog
  30. Pingback: seo in Malaysia
  31. Pingback: isle of mujeres
  32. Pingback: clima fresno
  33. Pingback: future university
  34. Pingback: Fiverr.Com
  35. Pingback: future university
  36. Pingback: lean six sigma
  37. Pingback: FUE
  38. Pingback: FUE
  39. Pingback: FUE
  40. Pingback: FUE
  41. Pingback: Storage solutions
  42. Pingback: Packing materials
  43. Pingback: Classic Books 500
  44. Pingback: FiverrEarn
  45. Pingback: FiverrEarn
  46. Pingback: FiverrEarn
  47. Pingback: FiverrEarn
  48. Pingback: FiverrEarn
  49. Pingback: FiverrEarn
  50. Pingback: Coach
  51. Pingback: Media
  52. Pingback: partners
  53. Pingback: FiverrEarn
  54. Pingback: live sex cams
  55. Pingback: live sex cams
  56. Pingback: FiverrEarn
  57. Pingback: FiverrEarn
  58. Pingback: FiverrEarn
  59. Pingback: FiverrEarn
  60. Pingback: FiverrEarn
  61. Pingback: FiverrEarn
  62. Pingback: FiverrEarn
  63. Pingback: FiverrEarn
  64. Pingback: website builder
  65. Pingback: website builder
  66. Pingback: FiverrEarn
  67. Pingback: FiverrEarn
  68. Pingback: FiverrEarn
  69. Pingback: FiverrEarn
  70. Pingback: cheap sex cams
  71. Pingback: live sex cams
  72. Pingback: rare breed-trigger
  73. Pingback: 늑대닷컴
  74. Pingback: Slot progresif
  75. Pingback: nang delivery
  76. Pingback: superslot
  77. Pingback: allgame
  78. Pingback: 918kiss
  79. Pingback: หวย24
  80. Pingback: Lipstick shades
  81. Pingback: pg slot
  82. Pingback: resort lake placid
  83. Pingback: itsMasum.Com
  84. Pingback: 25-06 ammo
  85. Pingback: itsMasum.Com
  86. Pingback: poei informatique
Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top